FOMAT

Increasing diversity

Clinical Trials Diversity – More Minorities Needed to Make Research Relevant to All

Minorities, in fact, account for fewer than 10 percent of patients enrolled in clinical trials, according to the National Institutes of Health (NIH) National Institute on Minority Health and Health Disparities. Today, Wilkins brings together academic researchers and community members to…

Read More
Clinical Research in Ecuador | Photo of Ecuador Flag

Clinical Research in Ecuador | Diversity in Hispanic Community Involvement

Why Is Diversity Important? FDA Action Plan In 2012 the Food and Drug Administration Safety and Innovation Act was published. Most of this FDA Action plan is based to encourage researchers to include safety and effectiveness data by demographic subgroups, including…

Read More
Insulin Therapy Innovation

Diabetes Research: Team Cures Diabetes in Mice Without Side Effects

Diabetes Research A potential cure for Type 1 diabetes looms on the horizon in San Antonio, and the Insulin Therapy Innovation would also allow Type 2 diabetics to stop insulin shots. The discovery, made at The University of Texas Health Science…

Read More
Juvenile Idiopathic Arthritis

Landmark Clinical Trial to Help Juvenile Idiopathic Arthritis Sufferers

A clinical trial funded by Arthritis Research UK and the National Institute for Health Research (NIHR), led by professors from the Universities of Liverpool and Bristol, has discovered a drug combination that could help thousands of children with Juvenile Idiopathic Arthritis….

Read More
Biotechnology Engineer

Inside FOMAT: Clinical Research Coordinator at FOMAT Involved in Important Research

Carla Geovanna Rodríguez Proaño is an Ecuadorian Biotechnology Engineer, who also obtained a master’s degree in Forensic Science, from King’s College in London. She has been conducting clinical research with FOMAT Medical Research since last year and was recently involved in…

Read More
Rheumatoid Arthritis Research

Rheumatoid Arthritis Research Provides New Insights on Risk Factors, Identification Tools, Intervention

Rheumatoid Arthritis Research Established wisdom holds that patients with rheumatoid arthritis (RA) will fare better if their disease is diagnosed as early as possible, and treatments with disease-modifying drugs are started before inflammation can do more damage to joints and tissue….

Read More
Hispanic cancer patients

How to boost Hispanics’ participation in clinical trials? Relate to them, study shows

Hispanic cancer patients rarely participate in clinical trials, but researchers want to tailor a Spanish DVD to help change this. To create a relevant educational tool, Moffitt Cancer Center researchers investigated why awareness of and participation in trials are so low…

Read More
Diabetic Brain Changes

Brain-computer Interface Allows ALS Patients to Communicate

A brain-computer interface that can decipher the thoughts of people who are unable to communicate could revolutionize the lives of those living with completely locked-in syndrome according to a new paper published in PLOS Biology. Counter to expectations, the participants in…

Read More
Early Alzheimer's detection

Early Signs of Alzheimer’s Disease Identified

Researchers from the University of Aberdeen have detected key changes in the brains of people with Alzheimer’s disease. The study confirmed for the first time that two molecules assumed to contribute to the disease process are both present at very early…

Read More